Core Laboratories (CLB) Depreciation & Amortization (CF) (2022 - 2026)

Core Laboratories' Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $3.8 million for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 1.26% year-over-year to $3.8 million in Q1 2026; TTM through Mar 2026 was $14.7 million, a 0.88% decrease from a year earlier, with the FY2025 full-year figure at $14.6 million, down 2.03% from the prior year.
• Depreciation & Amortization (CF) improved to $3.8 million in Q1 2026 per CLB's latest filing, from $3.7 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $4.4 million in Q2 2022 and bottomed at $3.6 million in Q3 2025.
• The 5-year median for Depreciation & Amortization (CF) is $3.8 million (2024), against an average of $3.9 million.
• Across the five-year window, Depreciation & Amortization (CF) declined 9.7% in 2023 and climbed 1.26% in 2026, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $4.1 million in 2022, then retreated by 4.89% to $3.9 million in 2023, then fell by 5.42% to $3.7 million in 2024, then rose by 0.11% to $3.7 million in 2025, then increased by 2.62% to $3.8 million in 2026.
• Per Business Quant, the three latest CLB Depreciation & Amortization (CF) figures stand at $3.8 million (Q1 2026), $3.7 million (Q4 2025), and $3.6 million (Q3 2025).